Why MetLife Stock Is Dropping Despite Analyst Optimism

Metlife ( ($MET) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.

MetLife shares are under pressure even as Wall Street turns more upbeat, because the latest move is driven by analyst expectations rather than fresh company news or results. The stock is slipping as some investors lock in gains and question whether the richer valuation now implied by higher forecasts and multiples has run ahead of fundamentals.

Only after that skepticism, investors are digesting the fact that Keefe Bruyette lifted its price target on MetLife to $105 while keeping an Outperform rating, citing stronger 2027 operating earnings, better free cash flow projections and a willingness to assign slightly higher valuation multiples. Several analysts are signaling a more favorable long-term outlook, but that shift has not yet translated into near-term share price support.

Looking further out, MetLife’s broad global footprint and large portfolio of high‑quality private assets give it multiple ways to grow earnings and investment income over time, which could help the business ride out regional slowdowns or market swings. Strong returns on equity and robust cash generation also suggest the company has room to keep funding dividends, buybacks and growth investments even in a tougher environment.

The key risk is that MetLife’s investment income and free cash flow have shown real ups and downs, and rising leverage leaves less room for error if markets or credit conditions turn. If volatility in fee and spread income persists while debt levels stay elevated, management may have to dial back capital returns or growth plans to protect the balance sheet, which could cap future stock performance.